Clinical Trial Information
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer
- Protocol Number: A032103
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Secondary Protocol No.: A032103
- Phase: II/III
- NCT ID: NCT05987241
Scope Information
- Scope:
- National
- Disease Site(s):
- Urinary Bladder
